Role of Myo-inositol and D-chiro-inositol on Oocyte Quality
Launched by AGUNCO OBSTETRICS AND GYNECOLOGY CENTRE · Apr 19, 2011
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • women undergoing IVF treatments
- • Body mass index \<28
- • FSH \<10IU/L
- • Normal uterine cavity, anatomy and functions
- Exclusion Criteria:
- • PCOS
- • Stage III or IV endometriosis
- • Premature ovarian failure
- • Poor responder
Trial Officials
Gianfranco Carlomagno, Ph.D.
Principal Investigator
AGUNCO Obstetrics and Gynecology Centre
Vittorio Unfer, M.D.
Principal Investigator
AGUNCO Obstetrics and Gynecology Centre
Franco Lisi, M.D.
Principal Investigator
Research Center for Reproductive Medicine
Enrico Papaleo, M.D.
Principal Investigator
San Raffaele Hospital
Scott Roseff, MD
Principal Investigator
The Palm Beach Center for Reproductive Medicine
About Agunco Obstetrics And Gynecology Centre
Agunco Obstetrics and Gynecology Centre is a leading healthcare facility dedicated to advancing women's health through innovative clinical research and evidence-based practices. Specializing in obstetrics and gynecology, the center is committed to improving patient outcomes by conducting rigorous clinical trials that explore new treatments and interventions. With a focus on patient safety and ethical standards, Agunco collaborates with experienced healthcare professionals to ensure high-quality research that addresses the unique needs of women. Through its initiatives, the center aims to contribute to the scientific community while enhancing the quality of care provided to its patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, , Italy
Roma, , Italy
Rome, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
